KC Sherrell

[KC Sherrell @kaarenshe]

@MariaBartiromo You ARE my favorite news person! I will follow you where ever you go. Please keep us posted. God has a better plan for you.

[Secretary Kennedy @SecKennedy]

Happening Now ⬇️
https://t.co/K2ChoBHFw3

[KC Sherrell @kaarenshe]

@AZFreeNews I agree it is totally inappropriate.

[KC Sherrell @kaarenshe]

@krassenstein Doesn't sound like Booing to me, just like the boo's for Biden sounded like Let's Go Brandon

[KC Sherrell @kaarenshe]

@AZFreeNews @CarineWerner My grand daughter qualifies for assistance and gets put through a long, difficult, bounce around, no help application process annually. Why do the fraudsters seemingly get through easily? Please also address the process and customer service. Thank you.

[KC Sherrell @kaarenshe]

@AZFreeNews Thank you Professor Owen Anderson!

[KC Sherrell @kaarenshe]

@SOCALEASTCOAST @HHSResponse @SecKennedy @SecWar What? Is that true?

[KC Sherrell @kaarenshe]

@AZFreeNews @maricopacounty Why do they wait until the June meeting when kids are out of school, families are traveling and many people are out of town and can't go to the meeting?

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[KC Sherrell @kaarenshe]

@Amothersanthem I am not able to make a donation on Give Send Go, saying something went wrong, can't find a place to give or update a CC

[KC Sherrell @kaarenshe]

@OG_Wick0 100% only team I do trust.

[KC Sherrell @kaarenshe]

@AZSecretary We are registering to vote nationally so I think our information should be transparent so we know national elections are secure too.

[KC Sherrell @kaarenshe]

@AZHouseGOP @Livingston4AZ @SteveMontenegro @MichaelCarbone @JWilloughbyAZ @NealCarterAZ @IsraelBachar_ Thank you for blessing AZ! Genesis 12:3.
"I will bless those who bless you, and I will curse him who curses you; and in you all the families of the earth shall be blessed." (NKJV)
Those who bless Abraham/Israel are blessed, and those who curse Israel are cursed.

[KC Sherrell @kaarenshe]

@BarronTNews_ I agree!

[KC Sherrell @kaarenshe]

@Merica197138 Thanks for investigating and reporting dangerous threats.

[KC Sherrell @kaarenshe]

@FoxNews @davidspunt @JakeBGibson All talk, no action. I will be happy to see accountability.

[KC Sherrell @kaarenshe]

@AZFreeNews @GinaSwoboda Is she the one who talked Schweikert into vacating this position?

[KC Sherrell @kaarenshe]

@AZSenateGOP @votewarren Thank you for all you do! You are our rock star.

[KC Sherrell @kaarenshe]

@BarronTNews_ A

[KC Sherrell @kaarenshe]

@femalebodybuil6 I think it's a cute picture. I approve.